Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: Subanalysis of Spanish results of an open-label study close to clinical.
Identifiers
Identifiers
Services
Services
Date issued
2014Journal title
Reumatología Clínica
Type of content
Artigo
